The most common question about Evidenza has no public answer. Here is everything we know, everything we can reasonably estimate, and what buyers should ask before signing.
The Pricing Page That Doesn't Exist
Navigate to evidenza.ai and you will find many things: a client list that reads like a Fortune 500 roll call, validation claims that cite EY and Dentsu, and a product suite that spans segmentation, positioning, creative testing, and the genuinely novel concept of "Synthetic CMOs" - AI clones of marketing luminaries like Byron Sharp and Mark Ritson.
What you will not find is a pricing page.
This is not unusual for enterprise software. Salesforce hides its real pricing behind sales calls. Palantir has never published a rate card. But in a market where competitors like Artificial Societies offer self-serve access at $40 per month and Ditto publishes transparent tier pricing, Evidenza's silence on cost creates a particular kind of friction. Buyers cannot budget for what they cannot see. Procurement teams cannot compare what they cannot quantify. And the question "What does Evidenza actually cost?" has become one of the most common queries from marketing leaders evaluating synthetic research platforms.
This article attempts to answer it - or, more precisely, to assemble the evidence that allows a reasonable estimate. Full disclosure: I am co-founder at Ditto, which competes in this space. I have tried to be thorough and fair. The reader can judge whether I have succeeded.
What Evidenza Charges: The Evidence
Evidenza's own FAQ is characteristically opaque: "Our pricing is customised based on the scope and complexity of your research needs. We offer premium, white-glove service packages... For detailed pricing, contact us directly to discuss your project and obtain a customised proposal."
The phrase "white-glove service" is doing considerable work in that sentence. It signals, correctly, that Evidenza is not a software subscription in the traditional sense. It is a managed research service - closer to hiring a boutique consultancy than to buying a SaaS tool. This distinction matters enormously when estimating cost.
The Data Points We Have
Several public sources provide triangulation:
Revenue and client count. Adweek reported in 2025 that Evidenza had generated over $1 million from operations with "more than a dozen clients." Simple arithmetic suggests an average engagement value of roughly $80,000-$100,000 per client. By mid-2025, The Drum reported "100+ clients" and described the company as profitable and entirely bootstrapped - meaning every dollar of revenue comes from customer contracts, not investor subsidies.
The GBP 500,000 reference. In The Drum's June 2025 feature, Peter Weinberg described a scenario in which "a GBP 500,000 study" was completed "in a week." Context matters here: this appears to reference the equivalent value of traditional research delivered at a fraction of the cost, not the price Evidenza charged. Weinberg's broader claim is "10 to 20 times cost savings and 100 times speed improvements" versus traditional methods.
The "fraction" framing. Mark Ritson, who sits on Evidenza's advisory board and is not known for his restraint when it comes to opinions, has written in Marketing Week that traditional B2B research costs "hundreds of thousands" or "high six figures," and that Evidenza delivers at "a fraction of that cost." A fraction of $200,000-$500,000 could mean many things, but it narrows the range.
The bootstrapped economics. Evidenza has raised precisely zero in external funding. Weinberg has described this as "deeply unfashionable in Silicon Valley." For a company with approximately 21 employees, advisors, and research partners to be profitable without venture capital, pricing must be sufficiently high to cover salaries, infrastructure, and margin on a pure-revenue basis. This is not a company optimising for growth at the expense of unit economics.
The Reasonable Estimate
Combining these signals, a reasonable estimate for Evidenza's annual engagement cost falls in the range of $50,000 to $100,000 per year, with variation depending on scope, the number of research modules used, and whether the engagement involves ongoing brand tracking or discrete project work. Individual projects or pilot engagements likely start lower - perhaps $15,000-$30,000 - but the platform appears designed for sustained enterprise relationships rather than one-off transactions.
It is worth noting that this estimate cannot be independently verified. Evidenza does not confirm or deny specific figures, and pricing may have shifted since these data points were published.
What That Money Buys
The pricing question is inseparable from the value question. Enterprise software buyers are accustomed to paying six figures annually for tools that replace seven-figure processes. The relevant comparison is not "Is $75,000 a lot of money?" but rather "What does $75,000 buy you at Evidenza versus the alternative?"
Evidenza's Six Modules
Evidenza organises its offering into distinct research capabilities:
Segmentation - Size addressable buyer pools, cluster by behaviour and needs, identify high-value segments
Positioning - Surface market beliefs, rank category entry points, align messaging to buyer mental models
Creative Testing - Score advertising on Evidenza's ABLE framework (Attention, Branding, Linkage, Equity), compare variants before media spend
Personas ("Impersonas") - Build detailed ideal customer profiles with buyer journey maps
Measurement - Track brand health over time, model scenarios, forecast ROI
Custom Research - Bespoke synthetic studies for questions that do not fit neatly into the above categories
Additionally, Evidenza offers access to its Synthetic CMOs - AI representations of marketing thinkers including Byron Sharp, Mark Ritson, and Binet & Field. These are, in effect, simulated advisory sessions: you present your strategy, and the AI-modelled expert critiques it through the lens of their published frameworks. Whether this is genuinely useful or slightly absurd depends, I suspect, on one's prior relationship with marketing theory. It is certainly distinctive.
The Full-Service Model
Critically, Evidenza's pricing covers not just software access but human service. The 72-hour turnaround from brief to completed research implies a team of analysts designing studies, quality-checking outputs, and synthesising findings. You are paying for expertise and curation as well as technology.
This is a legitimate value proposition for organisations that lack in-house research capability or that require consultancy-grade deliverables for board presentations and strategic decisions. ServiceNow credited Evidenza with helping them jump from 53rd to 41st in the Kantar BrandZ Global 100. SentinelOne reported receiving a comprehensive brand analysis in 24 hours versus an expected six months. These are meaningful outcomes.
The trade-off is flexibility. You cannot log in at midnight, run a study, and have results by breakfast. You cannot iterate five times in a day as new questions emerge from earlier findings. You cannot integrate results programmatically into your product development workflow via API. The white-glove model delivers polish at the expense of speed and autonomy.
How Evidenza Compares on Price
The synthetic research market has stratified rapidly into four pricing tiers. Understanding where Evidenza sits - and why - requires seeing the full landscape.
The Market Pricing Map
Tier | Platform | Approximate Cost | Model |
|---|---|---|---|
Budget | Artificial Societies | $40/month (unlimited) | Self-serve |
Conjointly | $1,895/year (Pro) | Self-serve | |
SYMAR | EUR 99/month | Self-serve | |
Mid-Market | Synthetic Users | $2-$27/respondent | Pay-per-use |
Yabble (YouGov) | $800/month | Self-serve | |
Quantilope | $22,000+/year | Enterprise | |
Premium | Tiered pricing (self-serve + enterprise) | Self-serve + API | |
Evidenza | Est. $50,000-$100,000/year | Full-service | |
Remesh | $3,500+/engagement | Per-project | |
Ultra-Premium | Est. $100,000-$250,000+/year | Enterprise-only | |
Aaru | Undisclosed | Enterprise-only |
Several observations emerge from this map.
Evidenza occupies the premium tier but not the top. Simile, backed by $100 million in Series A funding from Index Ventures and anchored by a Stanford pedigree and Gallup partnership, likely commands higher fees. Evidenza's bootstrapped profitability suggests pricing discipline - high enough to sustain the business, but not so high as to limit the addressable market.
The self-serve revolution is real. Three years ago, all synthetic research was enterprise-priced. Today, Artificial Societies offers unlimited access for less than the cost of a monthly coffee habit. This price compression has not yet reached Evidenza's segment, but it exerts gravitational pull. Weinberg has acknowledged this by listing "self-serve" as "coming soon" on the Evidenza website - a signal that the full-service-only model may be evolving.
Price and value are not the same thing. The cheapest option is not necessarily the best investment, and the most expensive is not necessarily the best research. A $40-per-month social media simulation tool and a $75,000-per-year enterprise research platform serve fundamentally different needs. Buyers who conflate them will make poor decisions in either direction.
The Hidden Costs
Published pricing - or estimated pricing - never tells the complete story. Several additional costs warrant consideration when evaluating Evidenza.
Time Cost
Evidenza's 72-hour turnaround is fast by traditional research standards and slow by self-serve platform standards. For organisations accustomed to commissioning research agencies (typical turnaround: 4-8 weeks), three days feels transformative. For product teams accustomed to self-serve tools that deliver in minutes, three days feels like an eternity.
The practical implication: Evidenza works well for strategic research planned in advance. It works poorly for ad hoc questions that arise during a sprint, a pricing meeting, or a product review. Organisations that need both strategic depth and tactical speed may find themselves maintaining two platforms.
Integration Cost
Evidenza currently offers no API access and no integrations with product development tools. Research findings arrive as reports, not as data feeds. For organisations that want to embed consumer insights into their design tools (Figma), content platforms (Canva), or development workflows (via Claude Code or similar AI coding agents), this creates a manual handoff that adds latency and friction.
This is not a trivial consideration. The trend in market research is toward continuous, embedded insight - research that lives inside the tools teams already use, not in slide decks that arrive days later. Evidenza's full-service model is optimised for a different paradigm.
Switching Cost
Enterprise engagements, by their nature, create lock-in. If your brand tracking, segmentation, and creative testing all run through Evidenza, migrating to an alternative requires rebuilding baseline data, retraining teams, and potentially losing historical comparability. This is true of any enterprise platform, but it is worth acknowledging that the high entry price also implies a high exit cost.
What Buyers Should Ask
For marketing leaders considering Evidenza, the pricing conversation should extend beyond "How much?" to include questions that determine whether the investment will deliver proportional value.
1. What is the minimum engagement? Evidenza's "customised proposal" language suggests flexibility, but buyers should establish whether a pilot project is available and at what price point. A $15,000-$25,000 pilot is a reasonable way to evaluate fit before committing to a six-figure annual contract.
2. What is the turnaround guarantee? The 72-hour claim appears frequently in press coverage. Buyers should confirm whether this is a median, a maximum, or a marketing claim, and whether it applies equally to all research types.
3. What happens to the self-serve roadmap? Evidenza has listed self-serve as "coming soon" for over a year. If a self-serve tier launches at a lower price point, will existing enterprise clients receive access? Will pricing change?
4. How is validation conducted? Evidenza cites 88% accuracy across 100+ validation tests, with specific correlations from Salesforce (0.81), Dentsu (0.87), and EY ("95% the same"). Buyers should ask whether these validations were conducted by independent third parties or by Evidenza itself, as the distinction affects reliability. For a deeper analysis of how different platforms validate their accuracy claims, see our comparison of self-reported versus independently audited validation. To date, no independently published audit of Evidenza's accuracy has appeared in the public domain.
5. What does "Synthetic CMO" access cost? It is unclear whether the Synthetic CMO feature (AI-modelled advisory from Sharp, Ritson, and Binet & Field) is included in all engagements or available as an add-on. Given that this is Evidenza's most distinctive feature, its pricing treatment matters.
Who Should - and Shouldn't - Pay These Prices
Not every organisation is an Evidenza customer, and recognising this early saves both parties time.
Evidenza is likely a strong fit if:
Your annual research budget exceeds $200,000 and you are looking to reduce cost whilst maintaining enterprise-grade deliverables
You need research outputs formatted for C-suite or board consumption, with the polish and narrative structure that executives expect
Your team lacks dedicated research staff and needs a managed service that handles study design, execution, and synthesis
You operate in B2B markets where Evidenza's positioning and segmentation modules directly address your research questions
You value the "Synthetic CMO" concept and want AI-modelled advisory alongside empirical research
Evidenza is likely not the right fit if:
You need research results in minutes rather than days - product teams running rapid iteration cycles will find the 72-hour turnaround too slow
You want API access to embed research into development workflows, CI/CD pipelines, or automated decision systems
Your primary use case is B2C consumer research, CPG product testing, or voter sentiment analysis - domains where Evidenza has limited demonstrated capability
You are a startup or growth-stage company for whom $50,000-$100,000 represents a material portion of your operating budget
You need to run dozens or hundreds of studies per year, where per-study economics matter more than per-engagement polish
The honest answer for many buyers is that they need both: a strategic research partner for high-stakes decisions and a self-serve platform for the daily questions that accumulate into product-market fit. The two models are not competitors so much as complements, and the organisations getting the most from synthetic research tend to use both.
The Broader Question
Evidenza's pricing opacity is, in a sense, the last vestige of a business model that is rapidly being disrupted. The traditional research industry operated on information asymmetry: agencies knew what research cost to produce, clients did not, and the margin lived in the gap. Enterprise software adopted a version of this model - "Contact sales for pricing" - as a way to maximise deal size through personalised negotiation.
The synthetic research market is split on whether this model persists. Evidenza and Simile are betting that enterprise buyers value service, curation, and prestige sufficiently to accept opaque pricing. Artificial Societies and Ditto are betting that transparency, self-serve access, and API integration will capture the larger and faster-growing segment of the market.
Both camps may be right. The enterprise segment - Fortune 500 CMOs commissioning strategic research for board-level decisions - will likely tolerate premium pricing and managed service for years to come. The mid-market and product-led segment - startup founders, product managers, growth teams running research in their development workflow - increasingly demands the pricing transparency and instant access that Evidenza does not currently offer.
The question for buyers is not "Is Evidenza too expensive?" It is "Does Evidenza's model match how my organisation wants to consume research?" If you need a research partner who delivers polished, expert-curated insights on a 72-hour cadence, the estimated $50,000-$100,000 annual investment may be excellent value. If you need an always-on research capability embedded in your product workflow, with API access and minute-level turnaround, you are shopping in a different aisle.
Phillip Gales is co-founder at Ditto, a synthetic research platform that competes with Evidenza. This article reflects publicly available information as of March 2026. Evidenza's actual pricing may differ from the estimates presented here.